Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy-Reference-Cited by-同舟云学术

Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy

Published:2021-06-24 Issue:8 Volume:22 Page:1052-1063
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Eschweiler Simon,Clarke James,Ramírez-Suástegui Ciro,Panwar Bharat,Madrigal Ariel,Chee Serena J.,Karydis Ioannis^ORCID,Woo Edwin,Alzetani Aiman^ORCID,Elsheikh Somaia,Hanley C. J.^ORCID,Thomas G. J.,Friedmann Peter S.,Sanchez-Elsner Tilman,Ay Ferhat^ORCID,Ottensmeier Christian H.^ORCID,Vijayanand Pandurangan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41590-021-00958-6.pdf

Reference72 articles.

1. De Simone, M. et al. Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells. Immunity 45, 1135–1147 (2016).

2. Linterman, M. A. et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat. Med. 17, 975–982 (2011).

3. Sage, P. T., Paterson, A. M., Lovitch, S. B. & Sharpe, A. H. The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells. Immunity 41, 1026–1039 (2014).

4. Sage, P. T., Alvarez, D., Godec, J., Von Andrian, U. H. & Sharpe, A. H. Circulating T follicular regulatory and helper cells have memory-like properties. J. Clin. Invest. 124, 5191–5204 (2014).

5. Sage, P. T., Francisco, L. M., Carman, C. V. & Sharpe, A. H. The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. Nat. Immunol. 14, 152–161 (2013).

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances;Signal Transduction and Targeted Therapy;2024-08-28

2. Molecular Susceptibility and Treatment Challenges in Melanoma;Cells;2024-08-20

3. Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy;Journal of Translational Medicine;2024-08-09

4. Fragile Treg cells: Traitors in immune homeostasis?;Pharmacological Research;2024-08

5. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy;Nature;2024-07-24